Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status

Detalles Bibliográficos
Autores principales: Yang, WH, Casale, T, Bateman, ED, Dahl, R, Pizzichini, E, Vandewalker, M, Virchow, JC, Engel, M, Moroni-Zentgraf, PM, Schmidt, H, Kerstjens, HAM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304131/
http://dx.doi.org/10.1186/1710-1492-10-S2-A52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304131/
http://dx.doi.org/10.1186/1710-1492-10-S2-A52

Ejemplares similares